June 13, 2018 / 5:08 AM / 3 months ago

BRIEF-Newron Pharmaceuticals Provides Update On STARS Clinical Study With Sarizotan For Treatment Of Rett Syndrome

June 13 (Reuters) - Newron Pharmaceuticals SpA:

* PROVIDES UPDATE ON STARS CLINICAL STUDY WITH SARIZOTAN FOR TREATMENT OF RETT SYNDROME

* TRIAL NOW EXPECTED TO COMPLETE ENROLLMENT IN H2 2018, WITH DATA READOUT EXPECTED IN H1 2019 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below